
Altesa BioSciences Announces Clearance of Investigational New Drug (IND) Application for Vapendavir
Altesa BioSciences, Inc., a clinical-stage pharmaceutical company dedicated to developing new treatments for viral infections in vulnerable populations, announced that the U.S. Food and Drug Administration (FDA) has cleared Altesa’s new Investigational New …